Re-treating gynecologic cancer with repeat radiation or ablation
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial studies using additional radiation or tumor-destroying techniques for gynecologic cancer that has come back after previous radiation treatment. It helps doctors understand if this approach is safe and effective for women with recurrent disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older at the time of treatment or enrollment
- You have a gynecologic cancer (like uterine, cervical, vaginal, vulvar, ovarian, or fallopian tube cancer) confirmed by biopsy
- You have received radiation therapy in the past as part of your cancer treatment
- Your cancer has come back or is getting worse, and your doctor plans to treat you again with radiation or other local treatments
- You have medical records showing details of your prior radiation and planned re-treatment
- You agree to participate and sign a consent form if required by local rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new combination treatment for ovarian cancer that has come back after earlier treatment. It aims to see if the combination can shrink tumors or slow the disease, and it may be an option for people whose cancer has become resistant to platinum-based chemotherapy.
This study tests giving radiation again to treat a cancer that has returned in the pelvic area (including the groin) when surgery isn’t a good option. It may help control the tumor while trying to protect nearby organs such as the small intestine.
This trial studies a “salvage” (next-line) cancer treatment for recurrent epithelial ovarian cancer, with or without a focused type of radiation. It may help by shrinking or controlling limited spots of cancer that have come back after prior standard treatment.
This study looks at combining total neoadjuvant therapy (chemotherapy and radiation) for rectal cancer that has come back in the pelvis after earlier radiation. It aims to see if this treatment approach can help control the disease and improve outcomes in patients with limited spread that can potentially be removed or treated.
This trial studies giving a second course of radiation to people whose cancer has come back or spread. It aims to see if more radiation can help control the cancer and improve quality of life.
This trial tests whether giving a second course of radiation therapy (called reirradiation) can safely treat lung cancer that has returned after earlier radiation. The goal is to control the cancer in the chest and see how well patients do with this repeat treatment.
Hear when a new Recurrent Vulvar Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.